NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches
Go back to NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches| (NASDAQ: NTHI) | Delayed: 2.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.90 | 52 Week High | $ | |||
| Open | $2.90 | 52 Week Low | $ | |||
| Day High | $2.90 | P/E | N/A | |||
| Day Low | $2.90 | EPS | $ | |||
| Volume | 6,408 | |||||



